Prof. Dr. Jennifer Hannig is a leading researcher in Explainable Artificial Intelligence (XAI) and computational biology at the Technical University of Mittelhessen's KITE Competence Center. Her work bridges AI transparency with applications in cardiology, digital pathology, and smart home technologies, focusing on interpretable algorithms for safety-critical domains. Junior Research Group Leader, TimeXAI project (2024-2027, €1.09M) Collaborations with Kerckhoff Clinic, CRS medical GmbH, and Veli GmbH Member of good scientific practice committee Mentor at Mentoring Hessen and AI Grid initiative Research Focus : Developing human-understandable XAI methods for time series classification, particularly in cardiovascular diagnostics and smart home monitoring. Her approach combines mathematical modeling (Petri nets) with deep learning to ensure reliable AI decision-making. Scientific Contributions : Key publications in PLOS Computational Biology , Frontiers in Digital Health , and Bioinformatics , with h-index of 8. Developed AI models for myocardial scar detection, Hodgkin lymphoma analysis, and manufacturing predictions. Poster Award – 1st Place (German Conference on Bioinformatics, 2013) ECCB 2016 Travel Award Contact: jennifer.hannig@kite.thm.de
Catherine Merrick is a Senior Lecturer at the University of Cambridge, affiliated with the Cambridge Pathology Department. Her research bridges molecular genetics, cell biology, and parasitology to investigate the biology of the human malaria parasite Plasmodium falciparum , focusing on DNA replication dynamics, G-quadruplex structures, and epigenetic mechanisms underlying virulence. University of Cambridge Cambridge Pathology Department Her work emphasizes: Malaria pathogenesis and parasite biology G-quadruplex DNA/RNA motifs in gene regulation Epigenetic control of virulence gene expression Genome stability during replication Cell cycle checkpoints in protozoan parasites Implications for antimalarial drug development Recent publications highlight her exploration of DNA replication stress, histone lactylation, and G-quadruplex-targeted therapies across malaria and other pathogens. Her research integrates computational biology, structural analysis, and molecular genetics to address fundamental questions in parasitology and public health.
Professor Michael Inouye is a leading systems genomics and population health researcher at the University of Cambridge (Department of Public Health and Primary Care) and Baker Heart & Diabetes Institute (Melbourne). His work bridges statistical genetics, computational biology, and clinical translation, with a focus on cardiovascular/respiratory diseases and sustainable research practices. Director of Research (Research Professor) since 2021 Honorary Professorial Fellow at University of Melbourne since 2021 Co-leader of Cambridge Baker Systems Genomics Initiative since 2017 Research Interests include: Polygenic risk score development and clinical implementation Multi-omic integration (genomics, proteomics, microbiomics) Host-microbiome interactions in disease Sustainable computational methodologies Cardiometabolic disease prevention Scientific Contributions show leadership in: Developing the Polygenic Score Catalog infrastructure Creating environmentally sustainable algorithmic frameworks Elucidating microbiome contributions to chronic diseases Advancing multi-modal risk prediction models Integrating genetic and metabolic pathway analysis Recent Publications demonstrate expertise across: Polygenic score optimization for blood traits and diabetes Microbiome-disease interaction networks Computational sustainability in biomedical research Cardiovascular risk stratification Multi-omic data harmonization Genetic determinants of molecular phenotypes
Sean C. Murphy, MD, PhD is an Adjunct Associate Professor in Microbiology and Associate Professor in Laboratory Medicine at the University of Washington School of Medicine. He serves as Assistant Director of Clinical Microbiology and holds key leadership positions including Director of the Clinical Microbiology Division at Seattle Children's Hospital and Director of the Malaria Molecular Diagnostic Laboratory. His work bridges clinical microbiology, diagnostic development, and malaria research. Dr. Murphy earned his MD and PhD in Microbiology/Immunology from Northwestern University Feinberg School of Medicine (2001-2008), a Post-graduate Diploma in African Studies with Honors from the University of Cape Town (2000), and a BS in Microbiology with Honors from Iowa State University (1996-1999). He completed his Clinical Pathology Residency and served as Chief Resident in the Department of Laboratory Medicine at the University of Washington (2008-2011). Dr. Murphy's research program focuses on the immune response to complex infectious diseases, particularly malaria infection by Plasmodium parasites. His laboratory develops novel high-throughput T cell screening technologies to study poly-specific T cell repertoires induced by Plasmodium sporozoites using mouse models. The group explores synthetic biology-based T cell vaccines and novel methods to induce broadly protective immune responses against malaria. In collaboration with the Seattle Biomed Malaria Clinical Trials Center, Dr. Murphy conducts controlled human malaria infection studies to identify effective drug and vaccine candidates. His recent publications demonstrate a strong focus on malaria immunology, vaccine development, and diagnostic test improvement. The research spans from basic science investigations of Plasmodium liver stage development to clinical trials of monoclonal antibodies for malaria prevention and epidemiological studies of malaria transmission. His work shows increasing collaboration across disciplines including immunology, molecular biology, epidemiology, and clinical medicine. Dr. Murphy serves as a clinical investigator in Phase I/II studies at the Seattle Malaria Clinical Trials Center, the only West Coast-based controlled human malaria infection facility purpose-built in the US. His quantitative reverse transcription PCR assays for malaria detection are recognized as some of the most sensitive and robust molecular diagnostic assays worldwide, allowing detection of malaria parasites 3-4 days earlier than conventional blood smears. He is actively involved in promoting quality improvement initiatives for external quality assurance among a network of controlled human malaria infection centers across the US, Europe, Africa, and Australia. His work extends beyond malaria to include prosthetic joint infections, burn injury recovery, and age-friendly care for older adults, demonstrating a broad commitment to improving health outcomes through diagnostic excellence and translational research.
Dr. John Beckham, M.D., is a Professor in the Department of Internal Medicine and Chief of the Division of Infectious Diseases & Geographic Medicine at UT Southwestern Medical Center. Board certified in both internal medicine and infectious disease, Dr. Beckham joined the UT Southwestern faculty in 2023 after completing his medical degree and internal medicine residency at Baylor College of Medicine, followed by infectious disease clinical fellowship and postdoctoral neurovirology research training at the University of Colorado School of Medicine. Dr. Beckham's research focuses on viral pathogenesis, particularly flavivirus infections with emphasis on neurological complications. His laboratory has made significant discoveries regarding West Nile virus mechanisms, Zika virus RNA structures, and the role of alpha-synuclein in restricting RNA virus infections in the brain. His work spans virology, neuroimmunology, and vaccine development for emerging RNA viruses, with particular attention to how the brain's unique immune environment both prevents infections and potentially contributes to neurodegenerative conditions. Dr. Beckham's publication record demonstrates a strong focus on neurotropic viruses, with recent work examining SARS-CoV-2's neurological impacts, arboviral diseases, and the intersection of viral infections with neurodegenerative processes. His research combines molecular virology, immunology, and neuroscience to address fundamental questions about host-virus interactions in the central nervous system. Among his professional recognitions, Dr. Beckham is a Fellow of both the American College of Physicians and the Infectious Diseases Society of America. He also maintains active membership in numerous professional organizations including the American Society for Virology, American Society for Microbiology, American Association for the Advancement of Science, American Association of Immunologists, and the American Society of Tropical Medicine and Hygiene. As an academic leader, Dr. Beckham serves on the editorial board of the Journal of Neuroimmunology, acts as an ad hoc reviewer for multiple scholarly journals, and participates in National Institutes of Health grant review committees. He has contributed to 11 books and published numerous academic articles in his areas of expertise, establishing himself as a significant contributor to the fields of neurovirology and infectious diseases. The J. David Beckham Research Lab operates as a dynamic multidisciplinary team comprising virologists, immunologists, and neuroscientists who collaborate on fundamental discoveries in viral pathogenesis, vaccine immunology, and neuroimmunology. The lab maintains active projects investigating flavivirus pathogenesis, neuroimmune responses, and emerging viral threats, with particular emphasis on understanding how viruses interact with the specialized environment of the central nervous system.
Julia Felippe is a Professor at Cornell University’s College of Veterinary Medicine , where she leads the Equine Clinical Immunology Laboratory and serves as Associate Chair for the Department of Clinical Sciences. Her work spans clinical care, DVM/resident training, and groundbreaking research in equine immunology. Education: PhD in Immunology (Cornell, 2002), MS in Veterinary Science (Kansas State, 1997), MedVet (UNESP-Botucatu, 1989) Research Focus: Dr. Felippe investigates developmental immunology in foals and mechanisms of equine immunodeficiencies, notably Common Variable Immunodeficiency (CVID). Her team identified epigenetic gene silencing in CVID-affected horses and pioneered regenerative therapies using hematopoietic stem cell modification. Publications & Impact: With over 200 peer-reviewed articles and a seminal textbook ( Equine Clinical Immunology , Wiley-Blackwell, 2016), her work intersects veterinary medicine, epigenetics, and conservation biology. Recent studies explore vaccine response optimization, R. equi pathogenesis, and cross-species applications in rhino/elephant conservation. Awards & Leadership: Recognized by the NIH New Innovator Award (2010) and the Zweig Chair (2005-2008), she directs the Cornell Veterinary Educators Academy and mentors global researchers. Her lab’s collaborations span institutions like Texas A&M, Mount Sinai, and the Javan Rhino Conservation Program.
Dr. Tine van Werven is an Associate Professor in the Farm Animal Health Department at Utrecht University's Faculty of Veterinary Medicine. With over 30 years of academic career, she has established herself as a leading researcher in dairy cattle health, particularly focusing on mastitis, digital dermatitis, and reproductive disorders. Her research interests span veterinary epidemiology, antimicrobial use in dairy farming, herd health management, and disease prevention strategies. Dr. van Werven's work consistently addresses practical challenges faced by dairy farmers while maintaining scientific rigor. She has made significant contributions to understanding digital dermatitis management, udder health, and the economic implications of reproductive disorders in dairy herds. Analysis of her recent publications reveals a strong focus on practical veterinary solutions, with particular emphasis on non-antibiotic treatments for foot disorders, mastitis diagnostics, and the complex relationship between farm management practices and animal health outcomes. Her work frequently examines the human dimensions of veterinary medicine, including farmer behavior and attitudes toward disease prevention. Dr. van Werven maintains an extensive collaborative network across European research institutions and has supervised numerous graduate students throughout her career. Her research has been consistently funded through competitive grants that support translational veterinary science with direct applications to dairy farming practices. She actively contributes to veterinary epidemiology through her position at Utrecht University, where she participates in both teaching and research activities focused on improving dairy cattle health and welfare through evidence-based approaches.
Estefania Lozano Andres is an Assistant Professor at Utrecht University's Department of Biomolecular Health Sciences (Faculty of Veterinary Medicine). She specializes in Extracellular Vesicles and Flow Cytometry , focusing on their applications in biomarker discovery, immunology, and molecular biology. Key Expertise: Flow Cytometry, Extracellular Vesicle Analysis, Molecular Biology Research Themes: Life Sciences Research Focus: Her work investigates the fundamental properties of extracellular vesicles (EVs), including their role in intercellular communication, disease progression, and diagnostic applications. She develops advanced flow cytometry methodologies for EV characterization and contributes to standardization frameworks like MIFlowCyt-EV. Scientific Leadership: She manages Utrecht's Center for Flow Cytometry and FACS (CFC), advancing high-dimensional analysis and panel design. Her awards include multiple international travel grants (2019-2022) and mobility fellowships from Autonomous University of Madrid. Recent Publications: Over 15 articles (2019-2025) address: EV-biomarker relationships in equine osteoarthritis Fluorescence calibration challenges in nanoparticle analysis EV-lipoprotein interactions CRISPR/Cas9-based antiviral discoveries Collaborations: Active in global EV research networks, including the International Society for Extracellular Vesicles. Her work intersects with UN Sustainable Development Goals for health innovations.
Dongyi Wang is an Assistant Professor in the Department of Biological and Agricultural Engineering at the University of Arkansas, where he directs the Smart Agriculture and Food Engineering (SAFE) Lab. His work bridges advanced technologies like artificial intelligence, robotics, and machine vision with agrifood manufacturing to enhance product quality, safety, and worker welfare. Ph.D. in Bioengineering from the University of Maryland, College Park B.S. in Electrical and Computer Engineering from Fudan University Visiting experience at The Chinese University of Hong Kong Research interests span smart agrifood manufacturing , robotics , machine vision , and artificial intelligence , with applications in crop monitoring, food safety, and healthcare. His lab develops solutions like automated defect detection, pathogen sensing, and sustainable processing systems. Article analysis reveals a focus on AI-driven agricultural automation , hyperspectral imaging , robotic manipulation of bio-products , and food safety innovations . Recent works include YOLO-based tomato defect segmentation, E. coli biosensing, and UAV-based blackberry monitoring. Awards & Memberships College of Engineering Dean’s Award of Excellence Rising Star Research Award (UARK) Outstanding Mentor Award (UARK) Professional memberships in ASABE and IEEE As an educator, he teaches instrumentation and artificial intelligence in agrifood manufacturing . The SAFE Lab, funded by USDA NIFA, NSF, and federal/local agencies (> $7M), prioritizes workforce development in AI/robotics for agrifood industries.
Dr. Bledar Bisha is an Associate Professor in Food Microbiology at the University of Wyoming's Department of Animal Science. With a dual appointment as an Affiliate Assistant Professor at Iowa State University, he focuses on developing innovative strategies for foodborne pathogen detection, microbial source tracking, and combating antimicrobial resistance across food and environmental systems. Mjek Veteriner (D.V.M), Veterinary Medicine, Agricultural University of Tirana M.S. & Ph.D. in Food Science & Technology, Iowa State University Postdoctoral Fellow in Food Microbiology, Colorado State University His research encompasses multi-omics approaches for microbial analysis, microfluidic biosensors for rapid diagnostics, and single-cell microbiology techniques. Recent work emphasizes microbial source tracking in water systems and antimicrobial resistance ecology in livestock-wildlife interfaces. Publications show a strong focus on foodborne pathogens (Listeria, Salmonella, E. coli), antimicrobial resistance in agricultural and environmental contexts, and innovative detection methods including paper-based microfluidics and mass spectrometry. He has contributed to understanding resistance gene transfer dynamics and developed novel sample preparation strategies for pathogen surveillance. 2019–Present: Associate Professor, University of Wyoming 2018–Present: Affiliate Assistant Professor, Iowa State University 2009–2013: Postdoctoral Fellow, Colorado State University 2002–2009: Graduate Research Assistant, Iowa State University Dr. Bisha teaches advanced courses in food microbiology and safety, while leading interdisciplinary research bridging agricultural practices, public health, and analytical technology development.
Alan B. Diekman is a Professor in the Department of Biochemistry and Molecular Biology at the University of Arkansas for Medical Sciences, College of Medicine, and an Associate Member of the Winthrop P. Rockefeller Cancer Institute. His research focuses on glycoconjugates in the mammalian reproductive tract, particularly CD52's role in sperm maturation, fertilization, and immune infertility. Education: Ph.D., Northwestern University B.S., Hope College His work explores structural and functional aspects of sperm glycocalyx modifications, including galectin interactions, carbohydrate epitopes, and their implications for immunocontraception. Publications highlight galectin-3, CD52 glycoforms, and calcium-binding proteins in seminal plasma and sperm membranes. Research trends include analyzing glycosylation patterns in reproductive biology, protein-prostasome associations, and developing animal models for contraceptive vaccines. Key collaborations span the Herr Lab and institutions like the Rockefeller Cancer Institute. Contact details: Email: DiekmanAlan@uams.edu Office: 501-686-5812 (Biomedical Research Center 421B) Lab: 501-686-5195 (Biomedical Research Center 419)
Dr. Jacques Ravel is a Professor of Microbiology and Immunology at the University of Maryland School of Medicine. He serves as the Acting Director of the Institute for Genome Sciences and Director of the Center for Advanced Microbiome Research & Innovation (CAMRI). Additionally, he holds the position of Assistant Dean for Research Advancement at the School of Medicine. Dr. Ravel received his educational training through the following path: B.Sc. in Biology and Chemistry from the University of Nancy I, France (1990) M.Sc. in Microbiology from the University of Nancy I, France (1992) Ph.D. in Microbial Ecology from the University of Maryland at College Park (1994-1999), advised by Dr. Russell Hill Post-doctoral fellowship at The Johns Hopkins University Chemistry Department (1999-2002), working with Dr. Craig Townsend Dr. Ravel's research program focuses on applying modern genomics technologies and ecological principles to characterize the role and dynamics of microbial communities inhabiting the human body in health and disease. His work particularly emphasizes deciphering the role of the vaginal microbiome in women's health using clinical genomics and systems biology approaches. His laboratory investigates how the interactions between the host, microbes, and environment drive these ecological systems, with the goal of developing improved strategies to manage gynecological and obstetrics conditions. His research spans vaginal microbiome dynamics across menopause, preterm birth risk, and sexually transmitted infections. Dr. Ravel's extensive publication record (over 275 publications) reveals a strong focus on vaginal microbiome research, with particular attention to bacterial vaginosis, sexually transmitted infections, and women's health across different life stages. His work spans methodological development for microbiome analysis, clinical studies of microbiome-host interactions, and translational research aimed at developing microbiome-based interventions. Dr. Ravel has received significant recognition for his work: Elected to the American Academy of Microbiology in 2012 Awarded the Blaise Pascal International Research Chair in 2015 Editor in Chief of the journal Microbiome Associate Editor for the journal mBio As a principal investigator and co-investigator, Dr. Ravel leads multiple NIH-funded research projects. His current grants span topics including vaginal microbiome dynamics across menopause, preterm birth risk among Black women, development of 3D biomimetic models of the cervicovaginal tract for studying STIs, and interactions between vaginal microbiota and Chlamydia trachomatis infection. Through these projects, he mentors numerous graduate students, postdoctoral fellows, and junior faculty. His co-Directorship of the NIH funded Collaborative Research Center on Sexually Transmitted Diseases (SIM-STI) demonstrates his leadership in developing innovative biomimetic models of the lower reproductive tract. Dr. Ravel directs the Center for Advanced Microbiome Research & Innovation (CAMRI) and co-directs the NIH-funded Collaborative Research Center on Sexually Transmitted Diseases (SIM-STI). His laboratory (www.ravel-lab.org) brings together microbiologists, genomicists, computational biologists, and clinicians to advance our understanding of the human microbiome and its implications for health and disease. He is also leading the Vaginal Microbiome Research Consortium for Africa, a multicentre prospective clinical study evaluating temporal vaginal microbial composition associated with reproductive health outcomes.
Craig B. Wilen, MD, PhD, serves as an Associate Professor in both Laboratory Medicine and Immunobiology at Yale School of Medicine. He holds dual appointments as Associate Professor of Laboratory Medicine (primary tenure) and Associate Professor on Term in Immunobiology. Dr. Wilen also serves as Medical Director of the Immune Monitoring Core Facility and is affiliated with multiple Yale research centers including the Center for Infection and Immunity, Center for RNA Science and Medicine, Human and Translational Immunology Program, and Yale Cancer Center. Dr. Wilen's educational background includes an AB in Biology and Economics from Washington University in St. Louis (2006), followed by combined MD/PhD training at the University of Pennsylvania Perelman School of Medicine (PhD 2011, MD 2013). He completed residency training in Clinical Pathology at Barnes-Jewish Hospital in St. Louis (2016) and conducted postdoctoral studies in the laboratory of Herbert 'Skip' Virgin at Washington University School of Medicine. His research focuses on host-pathogen interactions of RNA viruses, particularly coronavirus and norovirus. Dr. Wilen discovered CD300lf as the first receptor for norovirus and identified intestinal tuft cells as the physiologic target cell for mouse norovirus infection. Current work in the Wilen Lab investigates mechanisms of immunity and pathogenesis for noroviruses, coronaviruses, and pre-emergent viruses with pandemic potential. His research employs cutting-edge approaches including genome-wide CRISPR screens, animal models, and human tissue studies to understand viral entry, immune evasion, and pathogenesis. Analysis of Dr. Wilen's recent publications (2023-2025) reveals consistent focus on viral pathogenesis mechanisms across multiple RNA virus families. His work bridges basic virology with translational applications, examining viral receptors, host immune responses, and potential therapeutic interventions. The publications demonstrate strong collaborative networks across Yale and with external institutions, particularly in the areas of norovirus persistence mechanisms and coronavirus host interactions. Young Faculty Award 2024 from DARPA Odyssey Award 2023 & 2022 from Smith Family Foundation Young Physician-Scientist Award 2021 from American Society for Clinical Investigation Robert E. Leet and Clara Guthrie Patterson Trust Mentored Research Award 2020 Dr. Wilen leads an active research program through the Wilen Lab at Yale School of Medicine, where his team investigates viral pathogenesis and immunity. As Medical Director of the Immune Monitoring Core Facility, he oversees critical infrastructure for immunological research at Yale. His laboratory maintains strong connections with clinical departments while pursuing fundamental questions about how viruses interact with host cells and immune systems. The lab's work has significant implications for developing improved diagnostics, therapeutics, and vaccines for viral diseases.
Professor Philip Doble is a Distinguished Professor at the University of Technology Sydney (UTS), leading the Elemental Bio-imaging Facility (EBF) within the School of Chemistry and Forensic Science. His work focuses on developing advanced analytical techniques, including laser ablation-ICP-MS and chip-based liquid chromatography systems, to address complex problems in metallomics, forensic science, and biomedical research. The EBF collaborates internationally and nationally, fostering innovations in metal distribution analysis, toxicology, and disease mechanisms. His research spans multiple disciplines, including the role of trace metals in infectious diseases, cancer biomarker identification, and environmental exposure studies. Notable achievements include the 2013 Vice Chancellor's Award for Research Excellence. Current funded projects include coral resilience studies and metastatic breast cancer diagnostics. Doble supervises postgraduate students and actively contributes to forensic science advancements through interdisciplinary collaborations. Key research areas include: Analytical chemistry innovations for biological systems Metal interactions in host-pathogen interfaces Breast cancer biomarker quantification Environmental metal pollution analysis Neurological disease metallomics Grants and collaborations include projects on MRI contrast agent environmental impact, dystrophin-glycoprotein complex imaging, and forensic drug detection. His lab's cutting-edge technologies enable multiplexed elemental and biomolecular imaging, bridging analytical chemistry with clinical and environmental applications.
Professor Jinyan Li is an Adjunct Professor at the University of Technology Sydney's Data Science Institute, where he leads the Bioinformatics Program. His research develops computational methods for genomic analysis, protein interaction prediction, and biomedical data mining. Educational background: PhD in Computer Science (University of Melbourne) M.Eng in Computer Engineering (Hebei University of Technology) B.Sc in Applied Mathematics (National University of Defense Technology) Research spans: Genomic error correction algorithms Protein binding prediction Single-cell multi-omics analysis CRISPR design optimization Machine learning in bioinformatics With 140+ journal publications and 100+ conference papers, his work appears in leading venues including Bioinformatics, Nucleic Acids Research, and IEEE TKDE.
